Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Merck & Co., Inc. MRK

Healthcare  —  Drug Manufacturers General
148.78 0.80 0.54% as of 25 Sep
Market cap
$365.4B
P/E
119×
S&P 500 Member Dividend Aristocrat Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Merck & Co., Inc. (MRK) Price to free cash flow

As of 25 September 2026, Merck & Co., Inc. (MRK) trades at a price to free cash flow of 22.9×. Over the past ten years it has ranged from 10.9× (May 2025) to 487× (December 2020); the current reading is higher than 47% of that period. That is above the Drug Manufacturers General industry median of 17.7× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 21.3× 53.08%
FY2024 13.9× (55.70%)
FY2023 31.4× 64.22%
FY2022 19.1× (14.40%)
FY2021 22.4× (63.91%)
FY2020 61.9× 53.47%
FY2019 40.4× 72.62%
FY2018 23.4× (27.16%)
FY2017 32.1× 77.14%
FY2016 18.1× 43.70%

Quarterly

Period Price to free cash flow Change
Jun 2026 19.8× (6.21%)
Mar 2026 21.1× (1.13%)
Dec 2025 21.3× 32.78%
Sep 2025 16.0× 18.90%
42 more quarters

Against its own ten years

Low 10.9× High 487×
Ten-year median 23.4×
Current reading's percentile 47

Price to free cash flow against peers

Company Price to free cash flow
GILD Gilead Sciences, Inc. compare 14.5×
PFE Pfizer Inc. compare 16.0×
NVS Novartis AG compare 18.3×
NVO Novo Nordisk A/S compare 22.6×
MRK Merck & Co., Inc. 22.9×
AMGN Amgen Inc. compare 23.0×
ABBV AbbVie Inc. compare 25.7×
JNJ Johnson & Johnson compare 28.7×
AZN AstraZeneca PLC compare 41.2×
Drug Manufacturers General industry median 17.7×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on MRK